"Even those who had regained some slight weight still had 18% weight loss after on average, 4.5 years, with a standard commercial weight management program." No one took antiobesity drugs or had surgery.
Final data from SURMOUNT-3 (tirzepatide), real-world experience with the latest antiobesity drugs, a standards-of-care document in the works, and more will be featured at Obesity Week 2023 in Dallas.
Obesity Journal Symposium Spotlights Multi-Disciplinary Studies miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.